These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 8873615

  • 21. Identification of amino acid residues essential for heparin binding by the A1 domain of human von Willebrand factor.
    Adachi T, Matsushita T, Dong Z, Katsumi A, Nakayama T, Kojima T, Saito H, Sadler JE, Naoe T.
    Biochem Biophys Res Commun; 2006 Jan 27; 339(4):1178-83. PubMed ID: 16338223
    [Abstract] [Full Text] [Related]

  • 22. Type 2M:Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets.
    Mancuso DJ, Kroner PA, Christopherson PA, Vokac EA, Gill JC, Montgomery RR.
    Blood; 1996 Oct 01; 88(7):2559-68. PubMed ID: 8839848
    [Abstract] [Full Text] [Related]

  • 23. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
    Girma JP, Fressinaud E, Christophe O, Rouault C, Obert B, Takahashi Y, Meyer D.
    Thromb Haemost; 1992 Dec 07; 68(6):707-13. PubMed ID: 1287886
    [Abstract] [Full Text] [Related]

  • 24. Identification of the amino acid residues of the platelet glycoprotein Ib (GPIb) essential for the von Willebrand factor binding by clustered charged-to-alanine scanning mutagenesis.
    Shimizu A, Matsushita T, Kondo T, Inden Y, Kojima T, Saito H, Hirai M.
    J Biol Chem; 2004 Apr 16; 279(16):16285-94. PubMed ID: 14757772
    [Abstract] [Full Text] [Related]

  • 25. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
    Lanke E, Kristoffersson AC, Isaksson C, Holmberg L, Lethagen S.
    Eur J Haematol; 2008 Nov 16; 81(5):384-90. PubMed ID: 18637125
    [Abstract] [Full Text] [Related]

  • 26. Autoantibody selectively inhibits binding of von Willebrand factor to glycoprotein ib. Recognition site is located in the A1 loop of von Willebrand factor.
    Mohri H, Yamazaki E, Suzuki Z, Takano T, Yokota S, Okubo T.
    Thromb Haemost; 1997 Apr 16; 77(4):760-6. PubMed ID: 9134656
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of Binding of von Willebrand Factor to the Platelet Glycoprotein Ib-IX Complex, Heparin and Sulfatides by Polyanionic Compounds. The Mechanism of Modulation of the Adhesive Function of von Willebrand Factor.
    Andrews RK, Bendall LJ, Booth WJ, Berndt MC.
    Platelets; 1995 Apr 16; 6(5):252-8. PubMed ID: 21043709
    [Abstract] [Full Text] [Related]

  • 28. A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion.
    Perrault C, Moog S, Rubinstein E, Santer M, Baas MJ, de la Salle C, Ravanat C, Dambach J, Freund M, Santoso S, Cazenave JP, Lanza F.
    Thromb Haemost; 2001 Nov 16; 86(5):1238-48. PubMed ID: 11816713
    [Abstract] [Full Text] [Related]

  • 29. Functional expression of single chain glycoprotein Ib alpha on the surface of COS cells and BHK cells.
    Petersen EJ, Posthumus E, Sixma JJ.
    Thromb Haemost; 1996 Nov 16; 76(5):768-73. PubMed ID: 8950788
    [Abstract] [Full Text] [Related]

  • 30. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species.
    Zurbano MJ, Escolar G, Heras M, Ordinas A, Castillo R.
    Haematologica; 2000 May 16; 85(5):514-9. PubMed ID: 10800169
    [Abstract] [Full Text] [Related]

  • 31. Cytoplasmic truncation of glycoprotein Ib alpha weakens its interaction with von Willebrand factor and impairs cell adhesion.
    Schade AJ, Arya M, Gao S, Diz-Küçükkaya R, Anvari B, McIntire LV, López JA, Dong JF.
    Biochemistry; 2003 Feb 25; 42(7):2245-51. PubMed ID: 12590614
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of adhesive and signaling functions of the platelet GPIb-V-IX complex by a cell penetrating GPIbalpha peptide.
    David T, Ohlmann P, Eckly A, Moog S, Cazenave JP, Gachet C, Lanza F.
    J Thromb Haemost; 2006 Dec 25; 4(12):2645-55. PubMed ID: 17100656
    [Abstract] [Full Text] [Related]

  • 33. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
    Obert B, Houllier A, Meyer D, Girma JP.
    Blood; 1999 Mar 15; 93(6):1959-68. PubMed ID: 10068669
    [Abstract] [Full Text] [Related]

  • 34. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
    de Romeuf C, Hilbert L, Mazurier C.
    Thromb Haemost; 1998 Jan 15; 79(1):211-6. PubMed ID: 9459349
    [Abstract] [Full Text] [Related]

  • 35. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V.
    Kang M, Wilson L, Kermode JC.
    Blood Cells Mol Dis; 2008 Jan 15; 40(3):433-43. PubMed ID: 17977030
    [Abstract] [Full Text] [Related]

  • 36. O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors.
    Schulte Am Esch J, Robson SC, Knoefel WT, Hosch SB, Rogiers X.
    Xenotransplantation; 2005 Jan 15; 12(1):30-7. PubMed ID: 15598271
    [Abstract] [Full Text] [Related]

  • 37. Primary binding domain of bovine von Willebrand factor fragment expressed in E. coli.
    Bakhshi MR, Sinha D, Vora RK, Budzynski AZ, Kirby EP.
    Thromb Haemost; 1996 Jan 15; 75(1):196-202. PubMed ID: 8713801
    [Abstract] [Full Text] [Related]

  • 38. Characterization of bitiscetin-2, a second form of bitiscetin from the venom of Bitis arietans : comparison of its binding site with the collagen-binding site on the von Willebrand factor A3-domain.
    Obert B, Romijn RA, Houllier A, Huizinga EG, Girma JP.
    J Thromb Haemost; 2006 Jul 15; 4(7):1596-601. PubMed ID: 16839359
    [Abstract] [Full Text] [Related]

  • 39. Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domain.
    Shibata M, Shima M, Fujimura Y, Takahashi Y, Nakai H, Sakurai Y, Asatani M, Nomura A, Take H, Giddings JC, Yoshioka A.
    Thromb Haemost; 1999 May 15; 81(5):793-8. PubMed ID: 10365755
    [Abstract] [Full Text] [Related]

  • 40. Inhibition assay for the binding of biotinylated von Willebrand factor to platelet-bound microtiter wells in the presence of ristocetin or botrocetin.
    Miura S, Nishida S, Makita K, Sakurai Y, Shimoyama T, Sugimoto M, Yoshioka A, Ishii K, Kito M, Kobayashi T, Fujimura Y.
    Anal Biochem; 1996 May 01; 236(2):215-20. PubMed ID: 8660497
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.